Nanox Receives FDA Clearance for TAP2D Image Enhancement Capability, Advancing Goal of Removing Adjunct Use

Nanox has received FDA 510(k) clearance for TAP2D, a new image enhancement capability for its Nanox.ARC and Nanox.ARC X systems. This allows for a 2D image to be generated directly from a tomosynthesis scan, enabling both 3D and 2D views without additional radiation exposure. The clearance marks an important step in Nanox's regulatory strategy to position its tomosynthesis systems as primary diagnostic solutions.